Browsing Tag
Gibson Dunn
3 posts
Ligand Pharmaceuticals (LGND) to acquire XOMA Royalty (XOMA) for $739m as biotech royalty consolidation accelerates
Ligand is buying XOMA for $739 million in cash. The real story sits inside a CVR tied to a $19.7 billion Johnson and Johnson royalty fight.
OMEX surges 90% as Odyssey Marine Exploration agrees to merge with American Ocean Minerals
American Ocean Minerals and Odyssey Marine Exploration agree to $1B merger targeting deep-sea polymetallic nodules. What it means for U.S. critical minerals. Read more.
OcuMension secures Alcon eye drop rights with 16.7% stake, marking major strategic shift
OcuMension Therapeutics has struck a landmark deal with Alcon Inc., acquiring commercialization rights for a portfolio of eye…